Effects of a Stretching Protocol in Patients With Hip Osteoarthritis

Hip Osteoarthritis Clinical Trial

Official title:

Effects of a Stretching Protocol of Hip Flexors in Patients With Mild to Moderate Hip Osteoarthritis

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03702595
• Other study ID #: 1955
• Status: Completed
• Phase: N/A
• Start date: August 1, 2018
• Est. completion date: December 30, 2018

Study information

• Verified date: January 2020
• Source: Universidad de Zaragoza
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Hip osteoarthritis (OA) is one of the most prevalent chronic disease in the world. Clinical guidelines recommend non-pharmacological conservative treatments for the management of OA. Hip flexors seems to play an important role in the development of hip OA but there is no published studies evaluating the results of a stretching protocol of hip flexors in hip OA patients.

The objective of this trial is to evaluate if a stretching protocol of hip flexors is more effective in symptoms, functional capacity , range of motion, strength, muscular length, pain threshold and anxiety and depression compared to control.

For this purpose the investigators conduct a single-group, pretest-posttest clinical trial.The investigators included patients diagnosed of hip osteoarthritis Grade I-III by Scale of Kellgren and Lawrence.

The variables are measured at the beginning and at the end of treatment of the control phase, and at the end of the stretching protocol phase.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 15
• Est. completion date: December 30, 2018
• Est. primary completion date: November 30, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 50 Years to 70 Years

Eligibility

Inclusion Criteria:

• Diagnosed medically with a X-Ray test

• American College of Rheumatology Criteria

Exclusion Criteria:

• Secondary osteoarthritis by a traumatism, Paget disease, inflammatory or metabolic disease, congenital diseases etc.

• Vascular or neurological disease.

• Musculoskeletal pathologies in lumbar spine, pelvis or lower limbs

• Grade IV in Kellgren and Laurence Scale

Related Conditions & MeSH terms

• Hip Osteoarthritis
• Osteoarthritis
• Osteoarthritis, Hip

Intervention

Other:
• Hip flexors stretching protocol
Stretching protocol of rectus femoris, vastus lateralis and iliopsoas according to Kaltenborn- Evjenth Orthopaedic Manual Therapy Concept (OMT)

Locations

Country	Name	City	State
Spain	Sandra Jiménez del Barrio	Soria
Spain	Luis Ceballos Laita	Zaragoza

Sponsors (2)

Lead Sponsor	Collaborator
Universidad de Zaragoza	University of Valladolid

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Changes from baseline in pain intensity	Visual Analogic Scale	3 weeks
Secondary	Functional Capacity	The investigators measure the functional capacity with Timed Up and Go test (TUG)	3 weeks
Secondary	WOMAC questionnaire	WOMAC questionnaire	3 weeks
Secondary	Hip Range of Motion	Digital inclinometer according to Pua et al., 2008	3 weeks
Secondary	Muscular strength	The investigators measure the hip strength with a hand held dynamometer (Lafayette)	3 weeks
Secondary	Muscular length	The investigators measure the muscular length with an inclinometer	3 weeks
Secondary	Pressure Pain threshold	Pressure algometry measured by digital algometer	3 weeks
Secondary	Anxiety and Depression	Hospital Anxiety and Depression Scale (HADS)	3 weeks